Work

Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with Prostate Cancer

Year: 2011

Type: article

Source: Drugs

DOI: 10.2165/11588930-000000000-00000

Authors: Philip J. Saylor, Nancy L. Keating, Stephen J. Freedland, Matthew R. Smith

Institutions: Massachusetts General Hospital, Brigham and Women's Hospital, Harvard University, Duke University, Duke Medical Center, Durham VA Medical Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: AstraZeneca, National Institutes of Health, National Cancer Institute

Awards: Midcareer Investigator Award, G2975325711, G4163097709

OpenAlex ID: W2062357368

FWCI: 1.484

Cites: 53

Cited by: 14

Related to: 10